Drugs / BAM8-22
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06036589 | Mar → May 2022 | — | Aalborg University | Completed | No outcome recorded |
| — | NCT05249387 | Feb → May 2022 | — | Aalborg University | Completed | No outcome recorded |
| — | NCT04588532 | Oct 2020 → May 2021 | — | Aalborg University | Completed | No outcome recorded |
| — | NCT04197440 | Jan → May 2020 | — | Aalborg University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAM8-22 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06036589 ↗ |
| Known as | Bovine Adrenal Medulla | “With this experiment, the experimenter wish evaluate the role of TRPA1 on non-histaminergic itch induced by BAM8-22 2 (Bovine Adrenal Medulla), which is found naturally in the...” NCT06036589 ↗2“With this experiment, the experimenter wish to create a new model of itch based on the substance BAM8-22 (Bovine Adrenal Medulla), which is found naturally in the human body...” NCT04197440 ↗ “substance BAM8-22 (Bovine Adrenal Medulla) induce non-histaminergic itch.” NCT04588532 ↗ |
| Route | Topical | “20 µl of BAM8-22 will be applied to a previously determined area on the volar forearm followed by a prick through the drop” NCT04197440 ↗ |